Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of Alzheimer's Predictors in Subjective Memory Complainers - Extension Study
NCT05806697Recruiting
- Sponsor
- Inserm
- Start
- Apr 2023
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Inserm. Primary endpoint: Conversion to typical Alzheimer's Disease at 5 years. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05806697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806697.